We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRS icon
1201
Leonardo DRS
DRS
$12B
-4,789
Closed -$223K
DT icon
1202
Dynatrace
DT
$14.6B
-24,412
Closed -$1.35M
DTE icon
1203
DTE Energy
DTE
$28.5B
-2,299
Closed -$305K
DUOL icon
1204
Duolingo
DUOL
$6.42B
-2,264
Closed -$928K
DVN icon
1205
Devon Energy
DVN
$49.9B
-11,383
Closed -$362K
DXC icon
1206
DXC Technology
DXC
$1.74B
-13,400
Closed -$205K
DYN icon
1207
Dyne Therapeutics
DYN
$4.95B
-115,765
Closed -$1.1M
EBAY icon
1208
eBay
EBAY
$47.9B
-20,569
Closed -$1.53M
EBTC
1209
DELISTED
Enterprise Bancorp
EBTC
-18,943
Closed -$751K
ECO
1210
Okeanis Eco Tankers
ECO
$2.36B
-23,977
Closed -$521K
EE icon
1211
Excelerate Energy
EE
$1.13B
-6,993
Closed -$205K
EHC icon
1212
Encompass Health
EHC
$12.5B
-1,805
Closed -$221K
ELDN icon
1213
Eledon Pharmaceuticals
ELDN
$284M
-36,141
Closed -$97.9K
EMN icon
1214
Eastman Chemical
EMN
$8.39B
-2,945
Closed -$220K
ENPH icon
1215
Enphase Energy
ENPH
$5.41B
-9,769
Closed -$387K
ENVA icon
1216
Enova International
ENVA
$6.29B
-2,349
Closed -$262K
EPAM icon
1217
EPAM Systems
EPAM
$5.02B
-2,550
Closed -$451K
EPR icon
1218
EPR Properties
EPR
$4.63B
-12,668
Closed -$738K
ESGR
1219
DELISTED
Enstar Group
ESGR
-5,999
Closed -$2.02M
ESSA
1220
DELISTED
ESSA Bancorp
ESSA
-66,202
Closed -$1.28M
ETWO
1221
DELISTED
E2open Parent Holdings
ETWO
-240,701
Closed -$777K
EVCM icon
1222
EverCommerce
EVCM
$1.81B
-12,500
Closed -$131K
EVLV icon
1223
Evolv Technologies
EVLV
$1.05B
-17,884
Closed -$112K
EVRI
1224
DELISTED
Everi Holdings
EVRI
-214,051
Closed -$3.05M
EWA icon
1225
iShares MSCI Australia ETF
EWA
$1.47B
-7,816
Closed -$206K

Similar funds

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.